The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy

Molecular Therapy

Volumn 15, Issue 6, 2007, Pages 1040-1041

  Arruda, Valder R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DYSTROPHIN; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARVOVIRUS VECTOR; PREDNISONE; THYMOCYTE ANTIBODY;

ARTIFICIAL VENTILATION; CARDIOMYOPATHY; CELL THERAPY; CELL TRANSFER; CELLULAR IMMUNITY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE REPLACEMENT THERAPY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MUSCLE ATROPHY; MUSCLE NECROSIS; MUSCLE REGENERATION; MUSCLE WEAKNESS; MYOFIBROSIS; NONHUMAN; NOTE; RESPIRATORY FAILURE; SHORT COURSE THERAPY; TRANSGENE; VIRAL GENE THERAPY;

ANIMALS; DEPENDOVIRUS; DYSTROPHIN; GENE THERAPY; HUMANS; IMMUNOSUPPRESSION; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 34249311032     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300194     Document Type: Note

References (17)

1. Wang, Z, Kuhr, CS, Allen, JM, Blankinship, M, Gregorevic, P, Chamberlain, JS et al. (2007). Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol Ther 18: 1160-1166.
2. Sampaolesi, M, Blot, S, D'Antona, G, Granger, N, Tonlorenzi, R, Innocenzi, A et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
3. Nowak, KJ and Davies, KE (2004). Duchenne muscular dystrophy and dystrophin: Pathogenesis and opportunities for treatment. EMBO Rep 5: 872-876.
4. Radley, HG, De Luca, A, Lynch, GS and Grounds, MD (2007). Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol 39: 469-477.
5. Markham, LW, Spicer, RL, Khoury, PR, Wong, BL, Mathews, KD and Cripe, LH (2005). Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 26: 768-771.
6. Miller, RG, Sharma, KR, Pavlath, GK, Gussoni, E, Mynhier, M, Yu, P et al. (1997). Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle Nerve 20: 469-478.
7. Cooper, BJ, Winand, NJ, Stedman, H, Valentine, BA, Hoffman, EP, Kunkel LM et al. (1988). The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154-156.
8. Sharp, NJH, Kornegay, JN, Van Camp, SD, Herbstreith, MH, Secore, SL, Kettle, S et al. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13: 115-121.
9. Cerletti, M, Negri, T, Cozzi, F, Colpo, R, Andreetta, F, Croci, D et al. (2003). Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 10: 750-757.
10. Dell'Agnola, C, Wang, Z, Storb, R, Tapscott, SJ, Kuhr, CS, Hauschka, SD et al. (2004). Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104: 4311-4318.
11. Howell, JM, Lochmüller, H, O'Hara, A, Fletcher, S, Kakulas, BA, Massie, B et al. (1998). High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: Prolongation of expression with immunosuppression. Hum Gene Ther 9: 629-634.
12. Wang, Z, Allen, JM, Riddell, SR, Gregorevic, P, Store, R, Tapscott, SJ et al. (2007). Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum Gene Ther 18: 18-26.
13. Spencer, MJ, Montecino-Rodriguez, E, Dorshkind, K and Tidball, JG (2001). Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 98: 235-243.
14. Manno, CS, Chew, AJ, Hutchison, S, Larson, PJ, Herzog, RW, Arruda, VR et al. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972.
15. Arruda, VR, Stedman, HH, Nichols, TC, Haskins, ME, Nicholson, M, Herzog, RW et al. (2005). Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood 105: 3458-3464.
16. Su, LT, Gopal, K, Wang, Z, Yin, X, Nelson, A, Kozyak, BW et al. (2005). Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation 112: 1780-1788.
17. Davies, KE and Grounds, MD (2006). Treating muscular dystrophy with stem cells? Cell 127: 1304-1306.